6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (17%) |
| Double-patenting only | 2 (33%) |
| Double-patenting + other | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| HUYNH, PHUONG N | 1 | 65.7% | +53.6% |
| ROSSI, JULIA ANNE LORRAIN | 1 | 47.1% | +60.0% |
| BERHANE, SELAM | 1 | 59.0% | +55.8% |
| BREEN, KIMBERLY CATHERINE | 1 | 24.4% | +56.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270324 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY | BRETZ, COREY LANE | — |
| 17616870 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | BREEN, KIMBERLY CATHERINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796418 | ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF | BERHANE, SELAM | 146d overdue |
| 18017179 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | ROSSI, JULIA ANNE LORRAIN | 22d |
| 18024486 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | HUYNH, PHUONG N | 29d |
| 18692415 | DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES | AEDER, SEAN E | — |
| 17616870 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | BREEN, KIMBERLY CATHERINE | — |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1641 | 1 |
| 1615 | 1 |
| 1675 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692415 | DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES | AEDER, SEAN E | — | §112DP | Non-Final OA | — | Pending | Mar 15, 2024 |
| 18270324 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY | BRETZ, COREY LANE | 1635 | DP | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18024486 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | HUYNH, PHUONG N | 1641 | §102 | Final Rejection | 29d | Pending | Mar 02, 2023 |
| 18017179 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | ROSSI, JULIA ANNE LORRAIN | 1615 | DP | Non-Final OA | 22d | Pending | Jan 20, 2023 |
| 17796418 | ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF | BERHANE, SELAM | 1675 | §112DP | Final Rejection | 146d overdue | Pending | Jul 29, 2022 |
| 17616870 | METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES | BREEN, KIMBERLY CATHERINE | 1657 | §103§112DPOther | Non-Final OA | — | Pending | Dec 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial